Express -- With Arkray Piramal Medical Private Limited, NPIL and Kyoto, Japan based Arkray, Inc entered into a 49:51 JV to market diagnostic products, mainly SMBG (Self Monitoring Blood Glucose System) in the Indian market on December 9, 2007. The blood glucose system market in India is estimated to be more than Rs 1 billion in size and is estimated to be growing around 20 per cent p.a. Arkray, Inc is a market leader in the self-monitoring blood glucose market in Japan with a dominant market share. Its products are also distributed in over 80 countries around the world. Hidehiro Itokawa, Chairman and CFO, Arkay Piramal Medical Private Limited speaks to Sonal Shukla about the company’s offerings and expansion plans for India. Excerpts:
